Oct 7th, 2021
“We have a wild card here that is changing the risk-benefit equation for all babies in order to detect these rare cases.”
In this week’s episode of The G Word #sciencepodcast, our Chief Executive Officer, Chris Wigley, is joined by Dr Robert Green, Professor of Medicine (Genetics) at Harvard Medical School and a physician-scientist who directs the G2P Research Program in translational genomics and health outcomes in the Division of Genetics at Brigham and Women’s Hospital and Harvard Medical School. Additionally, Dr Green is principal investigator of the NIH-funded REVEAL Study and is internationally recognised for research and policy efforts accelerating the implementation of genomic/precision medicine.
Today Robert talks about his work around newborn sequencing with The BabySeq Project and what the programme is hoping to achieve. He also discusses Genomes2People and the research they conduct to accelerate the implementation of genomic medicine and the promise of precision health.